What is AbCellera Biologics Inc. Common Shares's Market Cap?

AbCellera Biologics Inc. Common Shares's Market Cap is $3.5B, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's Enterprise Value?

AbCellera Biologics Inc. Common Shares's Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's Price / Sales?

AbCellera Biologics Inc. Common Shares's Price / Sales is 53.0×, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's EV / Revenue?

AbCellera Biologics Inc. Common Shares's EV / Revenue is 51.2×, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's EV / EBITDA?

AbCellera Biologics Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's Revenue (TTM)?

AbCellera Biologics Inc. Common Shares's Revenue (TTM) is $66.2M, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's Net Income (TTM)?

AbCellera Biologics Inc. Common Shares's Net Income (TTM) is -$164.7M, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's EBITDA?

AbCellera Biologics Inc. Common Shares's EBITDA is -$200.0M, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's Diluted EPS (TTM)?

AbCellera Biologics Inc. Common Shares's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.

What is AbCellera Biologics Inc. Common Shares's EBITDA Margin?

AbCellera Biologics Inc. Common Shares's EBITDA Margin is -302.2%, based on as-reported figures from SEC (XBRL) filings.

AbCellera Biologics Inc. Common Shares (ABCL) Financial Statements

AbCellera Biologics Inc. Common Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00LLW2MH0

XNAS · usd

11.44▲ 0.01 (0.09%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close11.43

Day's Range11.10 – 11.64

52-Week Range2.75 – 12.58

Volume2.6M

Avg Volume8.2M

Share Statistics

Shares Outstanding

Employees562

ExchangeXNAS

Listed2020-12-11

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about AbCellera Biologics Inc. Common Shares (ABCL)

What is AbCellera Biologics Inc. Common Shares's Market Cap?: AbCellera Biologics Inc. Common Shares's Market Cap is $3.5B, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's Enterprise Value?: AbCellera Biologics Inc. Common Shares's Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's Price / Sales?: AbCellera Biologics Inc. Common Shares's Price / Sales is 53.0×, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's EV / Revenue?: AbCellera Biologics Inc. Common Shares's EV / Revenue is 51.2×, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's EV / EBITDA?: AbCellera Biologics Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's Revenue (TTM)?: AbCellera Biologics Inc. Common Shares's Revenue (TTM) is $66.2M, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's Net Income (TTM)?: AbCellera Biologics Inc. Common Shares's Net Income (TTM) is -$164.7M, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's EBITDA?: AbCellera Biologics Inc. Common Shares's EBITDA is -$200.0M, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's Diluted EPS (TTM)?: AbCellera Biologics Inc. Common Shares's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.
What is AbCellera Biologics Inc. Common Shares's EBITDA Margin?: AbCellera Biologics Inc. Common Shares's EBITDA Margin is -302.2%, based on as-reported figures from SEC (XBRL) filings.